Financial Performance - The company's operating revenue for Q1 2022 was ¥45,149,134.47, representing a 37.40% increase compared to ¥32,858,676.18 in the same period last year[4] - The net profit attributable to shareholders was ¥983,546.35, a significant turnaround from a loss of ¥804,516.25, marking a 222.25% improvement[4] - The basic earnings per share increased to ¥0.02 from a loss of ¥0.02, reflecting a 200.00% change[5] - The net profit for the first quarter of 2022 was 982,834.59, representing a 218.17% increase compared to the previous year, primarily due to increased operating income and government subsidies received[10] - Total profit amounted to 614,162.95, a significant increase of 157.35% from the previous year, attributed to higher government subsidies[10] - Operating profit decreased to -1,285,902.46, reflecting a 20.07% increase in losses due to increased R&D and business-related investments[10] - The company reported a total comprehensive income of CNY 945,884.38 for Q1 2022, compared to a loss of CNY 845,926.12 in the same period last year[29] Cash Flow and Financial Position - The net cash flow from operating activities improved by 27.82%, reaching -¥46,429,984.66 compared to -¥64,325,922.92 in the previous year[4] - Cash flow from investment activities showed a net outflow of -436,021,765.00, primarily due to the purchase of bank structured deposits[10] - The cash and cash equivalents at the end of the period were 158,392,289.88, a 47.90% increase attributed to funds raised from stock issuance[11] - The total cash and cash equivalents at the end of the period stood at 158,392,289.88 CNY, down from 650,420,992.55 CNY at the beginning of the period[33] - The net increase in cash and cash equivalents was -492,028,702.67 CNY, reflecting a substantial decline compared to -67,940,683.90 CNY in the previous quarter[33] Assets and Liabilities - Total assets decreased by 5.39% to ¥953,830,488.54 from ¥1,008,213,719.67 at the end of the previous year[5] - The company's total current assets were CNY 911,035,712.34, down from CNY 958,139,861.67 at the beginning of the year, indicating a decrease of about 4.9%[23] - The total liabilities decreased from CNY 189,738,885.49 to CNY 134,409,769.98, representing a reduction of approximately 29.2%[24] - The company's long-term receivables decreased from CNY 10,443,677.39 to CNY 5,253,895.85, a decline of about 49.7%[23] - The company's total equity remained stable at CNY 47,112,000.00, unchanged from the beginning of the year[24] Research and Development - The company reported a 55.00% increase in R&D expenses, totaling ¥4,833,962.90, indicating a focus on innovation and development[9] - Research and development expenses increased to CNY 4,833,962.90 in Q1 2022, up from CNY 3,118,683.26 in Q1 2021, reflecting a focus on innovation[28] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,517[13] - The largest shareholder, Lin Mingling, holds 28.43% of the shares, totaling 13,394,160 shares[13] Government Subsidies - The company received government subsidies amounting to ¥2,100,000.00 during the reporting period[7] - The company received government subsidies amounting to 1,999,635.00, marking an increase of 1,081.85% compared to the same period last year[10] Financial Expenses - The company’s financial expenses saw a significant increase of 272.36%, resulting in a net income of -¥1,545,721.31 due to increased interest income from cash management[9] - The company incurred financial expenses of CNY -1,545,721.31 in Q1 2022, a significant increase in income from interest compared to CNY 403,948.71 in Q1 2021[28] Board Restructuring - The company proposed a board restructuring, nominating five candidates for non-independent directors and three for independent directors, which was approved in the shareholder meeting held on March 4, 2022[17]